Effect of Riocigaut on Cerebral Vasodilation and Headache Induction in Healthy Volunteers

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 26, 2022

Primary Completion Date

June 1, 2023

Study Completion Date

June 1, 2023

Conditions

Headache

Interventions

DRUG

Dose Riociguat 2,5 or 5mg

A selective stimulator of soluble guanylate cyclase (sGC)

DRUG

Riociguat

A selective stimulator of soluble guanylate cyclase (sGC)

DRUG

Placebo

Trial Locations (1)

Danish Headache Center, Copenhagen

All Listed Sponsors

lead

Danish Headache Center

OTHER